Mupirocin recalls

The FDA has published 3 recalls involving Mupirocin since 2015. The latest was reported on 2 Oct 2024. Most were for potency & assay. GlaxoSmithKline has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2015

Last 12 months0reported

Class I00% of total

Ongoing0latest 2 Oct 2024

Recalls per month, last 24 months

click a bar for that month

1Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why mupirocin is recalled

Companies

By year

2024133%
2022133%
2015133%

All mupirocin recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
2 Oct 2024Drug	CLASS II	Mupirocin Ointment recalled by Glenmark PharmaceuticalsMupirocin	Glenmark Pharmaceuticals Inc., U	Potency & Assay	Nationwide
15 Jun 2022Drug	CLASS II	Mupirocin Ointment, USP 2% tube recalled by Mckesson Medical-SurgicalMupirocin	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
2 Sep 2015Drug	CLASS II	Mupirocin Calcium Cream, 2%, a) tube recalled by GlaxoSmithKline	GlaxoSmithKline	Other	Nationwide

Should you stop taking Mupirocin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.